Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Psyvox-ER 250 Tablet

Prescription Icon
Prescription Required

Marketer

Psychocare Health Pvt Ltd

Salt Composition

Divalproex (250mg)

Overview Psyvox-ER 250 Tablet

Epileptic seizures and migraine prophylaxis are key indications for the extended-release formulation of Psyvox 250mg tablets. This medication can also be employed, on occasion, as an adjunct therapy in managing bipolar disorder. Dosage and frequency are determined individually by your physician to optimize symptom control, and can be administered with or without food, but consistently at the same time daily for maximum effectiveness. Therapeutic efficacy typically manifests within a few weeks. Consistent adherence to the prescribed regimen is crucial; discontinuation or missed doses may exacerbate the underlying condition and potentially trigger seizures. Abrupt cessation is contraindicated. Commonly reported side effects include dizziness, nausea, vomiting, headache, blurred vision, fatigue, ataxia, easy bruising, and hypothermia; most resolve without intervention. Nonetheless, persistent or bothersome side effects warrant medical consultation. Immediate medical attention is required for any skin rash or redness. Long-term use may contribute to osteoporosis, increasing fracture risk, and, though rare, may precipitate suicidal ideation or behavior; report any depressive symptoms immediately. Prior to commencing therapy, disclose any history of cardiovascular disease, hepatic or renal impairment, urinary retention, depression, or suicidal tendencies. Drug interactions are possible; a complete medication list is essential for safe concurrent use. Consult your physician before initiating or discontinuing Psyvox 250mg tablets during pregnancy. Alcohol consumption should be avoided due to potential side effect exacerbation and heightened seizure risk. Regular blood monitoring, both pre- and post-treatment initiation, is often necessary to optimize therapeutic drug levels.

Uses of Psyvox-ER 250 Tablet

Managing epileptic seizures and bipolar disorder, along with migraine prevention.

Major Benefits of Psyvox-ER 250 Tablet:

Administer Psyvox-ER 250 Tablet as prescribed by your physician, ingesting the entire tablet without crushing, chewing, or breaking it. Consumption may coincide with meals or not, though consistent timing is recommended.

Common Side effects of Psyvox-ER 250 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Psyvox-ER 250 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Psyvox-ER 250 Tablets can be consumed with or without food, though consistent timing is recommended.

How Psyvox-ER 250 Tablet works:

Epileptic seizures are managed by NervControl 250mg, an anticonvulsant tablet. Its action reduces heightened, irregular neuronal firing within the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Psyvox-ER 250 Tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Psyvox-ER 250 Tablets during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Psyvox 250 mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Psyvox-ER 250 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Psyvox-ER 250 Tablets pose no safety concerns for patients with renal impairment; dose modification is unnecessary.

LiverLiverUNSAFE

Individuals with hepatic impairment should likely avoid Psyvox-ER 250 Tablets due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Psyvox-ER 250 Tablet :

Should you forget a Psyvox-ER 250 Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Psyvox-ER 250 Tablet

LabelValue
Chemical Category Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Anticonvulsant sodium channel blockers

FAQs on Psyvox-ER 250 Tablet

Always consult your doctor before discontinuing Psyvox-ER 250 Tablet. Withdrawal should be gradual, supervised by a healthcare professional, to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Psyvox-ER 250 Tablets may be used to stabilize mood in individuals experiencing rapid mood swings. This effect is achieved by reducing excessive brain activity associated with these mood changes.
Yes, Psyvox-ER 250 Tablet can lead to weight gain, possibly from increased appetite. Maintain a healthy diet and exercise regularly to minimize this risk. Consult your doctor if you have weight gain concerns.
Drowsiness is a possible side effect of Psyvox-ER 250 Tablet. Refrain from driving or operating machinery until you understand its effects on you.
Hair loss is a possible, temporary side effect of Psyvox-ER 250 Tablet, often linked to dosage. Consult your doctor if this occurs or continues.
Liver damage is a potential side effect of Psyvox-ER 250 Tablet, particularly within the first six months of treatment. Symptoms such as nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes) may indicate liver damage. Baseline liver function tests are recommended before starting the medication, with periodic testing during the initial six months, especially for at-risk individuals or those with a history of liver disease.
Refrain from drinking alcohol during your Psyvox-ER 250 Tablet treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Psyvox-ER 250 Tablet treatment, your doctor may order blood tests, such as a complete blood count (including platelets), bleeding time, and coagulation studies, to minimize the risk of bleeding or bruising. Liver function tests are also recommended before and, particularly for high-risk patients or those with a history of liver disease, during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting could indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may test your serum amylase levels; a positive result necessitates immediate medication discontinuation.
Psyvox-ER 250 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Symptoms may also include muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Psyvox-ER 250 Tablet
54
MRP 62
12% off